Welcome to a free event
Thursday 19 May 2022, 8:30–13:00 (EEST)
Team Finland House, Porkkalankatu 1, Helsinki
Have you ever been curious about Health and Life Sciences as an investment opportunity? Now is your chance: Welcome to the How to invest in Health & Life Sciences event in Helsinki on 19 May.
The specialised investors from the Nordics and beyond will guide you through what should be taken into consideration when investing in health & life science startups and what the industry’s investment landscape looks like.
During the half-day event you’ll learn:
- What is the investment roadmap and horizon for Health & Life Science investments?
- How do research-based innovations play out as investment opportunities?
- What are the growth drivers for Health & Life Sciences?
- What is the current status of Health & Life Science in Finland and Europe?
- How to build a successful Health & Life Science fund?
Thank you for attending!
Please find all the presentations here:
Harry Brade / Business Finland Venture Capital 190522
Pekka Simula & Milla Koistinaho / Innovestor Life Science Fund 190522
Carl Kilander / HealthCap 190522
Georgina Askeland / Hadean Ventures 190522
Joni Karsikas / Tesi 190522
Event details
When: Thursday 19 May,
8.30–13.00 (EEST), including morning coffee and lunch
Where: Team Finland House, Porkkalankatu 1, Helsinki (Business Finland auditorium, 1st floor)
Why: You’ll learn everything you need to when investing in Health & Life Sciences from seasoned international GP’s and LP’s.
For whom: Health & Life Sciences entrepreneurs, angel investors, institutional investors & family offices, tech transfer specialists, experts in the Health & Life Sciences sector, and anyone interested in investing in Health & Life Sciences and eager to network with like-minded.
The event is free of charge but registration is required. Welcome!
Detailed agenda will be announced during April.Topics:
- Diversity in the health and life science sector?
- What is the investment roadmap and horizon for Health & Life Science investments?
- How do research-based innovations play out as investment opportunities?
- What are the growth drivers for Health & Life Sciences?
- What is the current status of Health & Life Science in Finland and Europe?
Speakers:
- Harry Brade, Chairman of the Board, Business Finland Venture Capital
- Carl Kilander, Partner, HealthCap
- Georgina Askeland, Investment Associate, Hadean Ventures
- Milla Koistinaho, General Partner, Innovestor
- Pekka Simula, General Partner, Innovestor
- Joni Karsikas, Investment Director, Tesi (Finnish Industry Investment Ltd)
Panelists:
- Carl Kilander, Partner, HealthCap
- Georgina Askeland, Investment Associate, Hadean Ventures
- Petri Serenius, Investment Director, Business Finland Venture Capital
- Aki Koivistoinen, StartUp Health Ambassador, Europe & Israel
- Karita Meling, Head of Private Equity, Elo Mutual Pension Insurance Company
Q&A session with the panelists Business FinlandBusiness Finland Venture CapitalHealth Capital HelsinkiHealthtech Finland
From Health Capital Helsinki
